期刊文献+

双磷酸盐药物对合并骨质疏松行口腔外科手术患者术后感染的研究 被引量:5

Impact of bisphosphonate on postoperative infections in patients with osteoporosis undergoing oral surgery
原文传递
导出
摘要 目的分析服用双磷酸盐药物对骨质疏松的患者行口腔外科手术后发生的感染,控制围手术期相关药物的使用。方法采用回顾性研究方法对行手术治疗的骨质疏松患者临床资料进行分析,以术前5周是否有使用双磷酸盐类药物分为观察组和对照组,对两组患者基础指标及术后发生感染进行统计分析,并对药物使用时间及感染进行相关分析。结果共纳入患者213例,其中观察组148例,对照组65例,两组患者性别差异无统计学意义,观察组患者吸烟、饮酒、糖尿病分别为21.6%、27.7%、2.0%,对照组患者分别为26.2%、36.9%、3.1%,两组比较,差异无统计学意义;观察组术后27例发生感染,感染率18.24%,对照组4例发生感染,感染率6.15%,两组比较差异有统计学意义(P<0.05);进一步分析发现随着药物使用时间的增长,其感染率逐渐增大。结论双磷酸盐可增加口腔外科术后感染概率,对合并骨质疏松患者术前5周应酌情考虑停用或减量双磷酸盐类药物。 OBJECTIVE To evaluate the effect of bisphosphonates on the postoperative infections in the osteoporosis patients who underwent oral surgery so as to control the perioperative use of relevant drugs.METHODS The clinical data of the osteoporosis patients who underwent surgery were retrospectively analyzed,the patients were divided into the observation group and the control group according to the use of bisphosphonate during 5 weeks before the surgery,and the statistical analysis was performed on the basic characteristics and infection rates.Additionally,the correlation between the time of using antibiotics and the infections was analyzed.RESULTS A total of 213 cases were included,148 cases in the observation group,65 cases in the control group.The difference in the gender between the two groups was not statistically significant.In the observation group,the patients with smoking history accounted for 21.6%,the patients with drinking 27.7%,and the patients with diabetes mellitus 2.0%,and in the control group they were 26.2%,36.9%,and 3.1%,respectively,the difference between the two groups was not statistically significant.There were 27(18.24%) infected cases that were detected after the surgery in the observation group,while there were 4(6.15%) infected cases detected after the surgery in the control group,the difference was statistically significant(P0.05).Further analysis confirmed that there was a positive correlation between drug use time and the infection rate.CONCLUSION Bisphosphonates can increase the risk of infections after oral surgery.The osteoporosis patients should stop using or reduce the dosage of bisphosphonates during five weeks before the surgery.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2013年第4期833-835,共3页 Chinese Journal of Nosocomiology
关键词 双磷酸盐 骨质疏松 口腔颌面外科 感染 Bisphosphonates Osteoporosis Oral and maxillofacial surgery Infection
  • 相关文献

参考文献7

  • 1Hampson G,Fogelman I. Clinical role of bisphosphonate therapy[J].Int J Womens Health,2012.455-469.
  • 2郭培军,陈国华,张芳,刘自芬.双磷酸盐药物所致下颌骨坏死研究进展[J].现代肿瘤医学,2010,18(6):1238-1241. 被引量:8
  • 3Cartsos VM,Zhu S,Zavras AI. Bisphosphonate use and the risk of adverse jaw outcomes:a medical claims study of 714,217 people[J].Journal of the American Dental Association,2008,(01):23-30.
  • 4Vestergaard P,Schwartz K,Rejnmark L. Oral bisphosphonate use increases the risk for inflammatory jaw disease:a cohort study[J].Journal of Oral and Maxillofacial Surgery,2012,(04):821-829.
  • 5刘妹莲,林掌珠,邱丽心,张世阳,连羡玉.外科手术部位感染的目标性监测分析[J].中华医院感染学杂志,2011,21(20):4220-4222. 被引量:8
  • 6李丽,史艳红,龚瑶,孟庆冰,施玮,张媛.颌面部肿瘤手术切口感染调查分析及防范措施[J].中华医院感染学杂志,2010,20(22):3482-3484. 被引量:9
  • 7Ferretti G,Fabi A,Carlini P. Zoledronic-acid-induced circulating level modifications of angiogenic factors,metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients[J].Oncology,2005,(01):35-43.

二级参考文献33

  • 1丁国英,王婕玲.非生物性因素引发切口感染及对策[J].中华医院感染学杂志,2004,14(7):775-775. 被引量:44
  • 2李和姐,钱倩健,施晓群,吴佩雯,倪语星.瑞金医院医院感染与全国医院感染监测比较分析[J].中华医院感染学杂志,2004,14(2):144-147. 被引量:56
  • 3韩黎,朱士俊,郭燕红,李六亿,胡必杰,武迎宏,袁云娥.中国医务人员执行手卫生的现状调查[J].中华医院感染学杂志,2006,16(2):140-142. 被引量:630
  • 4任南,吴安华,冯丽,文细毛,易霞云,吕一欣,龚瑞娥,黄勋,王曼平.住院患者抗菌药物临床应用横断面调查[J].中华医院感染学杂志,2006,16(9):1048-1050. 被引量:210
  • 5Wooltorton E.Patients receiving intravenous bisphosphonates should avoid invasive dental procedures[J].CMAJ,2005,172 (13):1684.
  • 6Abu-Id MH,Acil Y,Gottschalk J,et al.Bisphosphonate associated osteonecrosis of the jaw[J].Mund Kiefer Gesichtschir,2006,10 (2):73-81.
  • 7Bamias A,Kastriris E,Bamia C,et al.Osteonecrosis of the jaw in cancer after treatment with bisphosphonates:incidence and risk factors[J].J Clin Oncol,2005,23(34):8580-8587.
  • 8Sanna G,Preda L,Bmschini R,et al.Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer[J].Ann Oncol,2006,17(10):1512-1516.
  • 9Landesberg R,Wilson T,Grbic JT.Bisphosphonate-associated osteonecrosis of the jaw:conclusions based on an analysis of case series[J].Dent Today,2006,25(8):52,54-57.
  • 10Treister N,Woo SB.Images in clinical medicine.Bisphosphonate associated osteonecrosis of the jaw[J].N Engl J Med,2006,355 (22):2348.

共引文献22

同被引文献46

引证文献5

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部